Canada's global leadership in regenerative medicine is threatened as outdated regulations and funding gaps force life-saving innovations abroad. The Stem Cell Network, in a pre-budget submission for this fall's Budget 2026, urges the federal government to implement a prioritized regulatory pathway for advanced therapeutics along with targeted early-stage investment to secure economic growth and faster patient access to domestic therapies.